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West syndrome (WS) is characterized by epileptic spasms (formerly, infantile 
spasms), a specific electroencephalographic (EEG) pattern (hypsarrhythmia), 
and psychomotor retardation beginning in the first year of life (1-5). This classic 
triad may vary in age (with its onset ranging from neonatal period to four 
years), spasms (asymmetrical or combined with other seizure types), modified 
hypsarrhythmia, and psychomotor function which can be normal or delayed [5]. In 
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Abstract
Objective 
We aimed to determine the clinical and electroencephalographic (EEG) 
characteristics of the patients with West syndrome (WS) in south Iran. 
Materials & Methods
In this retrospective study, all patients with a clinical diagnosis of WS 
were recruited in the outpatient epilepsy clinic at Shiraz University of 
Medical Sciences between September 2008 and May 2012. Age, gender, 
age at seizure onset, seizure type(s), epilepsy risk factors, EEG and 
imaging studies of all patients were registered routinely. 
Results
During the study period, 2500 patients with epilepsy were registered 
at our epilepsy clinic. Thirty-two patients (1.3%) were diagnosed to 
have WS. Age of onset (mean ± standard deviation) was 4.99 ± 3.06 
months. Sixteen patients were male and 16 were female. Nine (28.1%) 
were reported to have two or more seizure types and 23 (71.8%) had one 
seizure type (epileptic spasms). At referral, no developmental delay was 
detected in two patients and in the rest, a mild to severe delay was noted. 
Electroencephalography showed typical hypsarrhythmia in 59.4% of 
our patients and modified hypsarrhythmia or atypical presentations were 
seen in 40.6%. Two patients had pyridoxine (B6)-dependent seizures, 
confirmed by oral B6 trial.
Conclusion
Variants of the classical triad of WS including other seizure types, atypical 
EEG findings, and normal psychomotor function at the beginning could 
be observed in some patients. Rarely, treatable genetic disorders (e.g., 
pyridoxine-dependent seizures) should be considered in those in whom 
no other diagnosis is evident.
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the current study, we tried to determine the clinical and 
electroencephalographic characteristics of patients with 
WS in south Iran.
Materials & Methods
In this cross-sectional retrospective chart review study, 
all patients with a clinical diagnosis of WS were recruited 
at the outpatient epilepsy clinic at Shiraz University of 
Medical Sciences, the only epilepsy clinic in south Iran, 
from September 2008 to May 2012. The diagnosis of 
WS was made based on the clinical and EEG grounds. 
All patients were visited by an epileptologist at our 
institution. Out-patient EEG (either awake or sleep) was 
performed in all patients at the time of referral. The high 
frequency filter was set to 70 hertz (Hz) and the low 
filter was at 0.16 Hz. In-patient video-EEG monitoring 
study was performed when considered necessary for 
confirmation of the diagnosis or planning the treatment 
strategy. The study time for the video-EEG monitoring 
was 120 minutes and recording both wakefulness and 
sleep was required in all patients. Brain imaging study 
(magnetic resonance imaging [MRI]) was performed 
when possible. Other tests (e.g., blood works) were 
requested based on the clinical judgment.
We studied the demographic, clinical, EEG, and imaging 
findings. Age, gender, age at seizure onset, seizure type(s), 
epilepsy risk factors (including history of perinatal 
complications or significant head trauma, history of 
febrile seizure, positive family history of epilepsy and 
parental consanguinity), EEG and imaging studies of 
all patients were recorded. Demographic variables and 
relevant clinical and EEG variables were descriptively 
summarized to characterize the study population. This 
study was approved by Shiraz University of Medical 
Sciences Review Board.
Results
During the study period, 2500 patients with epilepsy 
were registered at our epilepsy clinic. Thirty-two patients 
(1.3%) were diagnosed to have WS. Age of onset (mean 
± standard deviation) was 4.99 ± 3.06 months (range; 
neonatal period to 12 months of age). Figure 1 shows the 
age of onset in patients with WS. 
Sixteen patients were male (50%) and 16 (50%) were 
male. Nine patients (28.1%) were reported to have two 
or more seizure types and 23 (71.8%) had only epileptic 
spasms. Epileptic spasms, tonic, atonic, generalized 
tonic-clonic, and myoclon seizures were reported in 
30 (93.7%), 8 (25%), 2 (6.2%), 1 (3.1%), and 1 (3.1%) 
patients, respectively.
Epilepsy risk factors were reported to be as follow: 
perinatal complications in 12 patients (37.5%; including 
hypoxic-ischemic insults in 8 [25%] and sepsis, low-
birth-weight, and hyperbilirubinemia in other four), 
family history of epilepsy in four (12.5%), and parental 
consanguinity in 13 (40.6%).
At referral, two patients did not have developmental 
delay while the rest had a mild to severe developmental 
delay. Many patients had medical or neurological 
comorbidities including cerebral palsy in 13 (40.6%), 
tuberous sclerosis in two (6.2%), intra-uterine infection 
by cytomegalovirus in one (3.1%), hypothyroidism in 
one (3.1%), and congenital heart disease in one (3.1%).
We requested EEG for all patients at the time of referral 
(Table 1). Brain MRI was done only in 30 patients 
because other two could not afford its cost. The results 
are summarized in Table 2. Blood works were not 
performed in 10 patients. When it was performed, it was 
not conclusive in most cases. However, lactic acidosis 
and hyperammonemia were detected in four and two 
cases, respectively. Two other patients had pyridoxine 
(B6)-dependent seizures confirmed by oral B6 trial.
Eight cases had new-onset disease diagnosed at our 
clinic and the rest were referred from other centers after 
being treated for some time. All patients with newly 
diagnosed WS had epileptic spasms. One also had tonic 
seizures. Five patients had hypsarrhythmia in their EEGs 
while three had multifocal spikes and slow spike-wave 
complexes. Brain MRI was normal in three patients but 
showed atrophy in two and schizencephaly in one.
Discussion
West syndrome is a rare epileptic encephalopathy 
characterized by epileptic spasms, typical 
electroencephalographic patterns, and psychomotor 
retardation (1-5). The frequency of this syndrome was 
1.3% in both children and adults in our clinic. This is 
similar to the previous reports in this regard (6, 7). In 
a study from Hong Kong, 1.9% of the children with 
epilepsy had WS (6). Clinical manifestations of WS are 
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seizures. Resuscitation equipments should therefore be 
available during an intravenous trial (9). Alternatively, 
the disorder may be diagnosed by giving 15 mg/kg/
day of oral B6 to an infant who experiences frequent 
seizures. Complete control of the seizures within a week 
or so is confirmatory in these situations (9, 12). Once the 
diagnosis is confirmed, maintenance therapy (25 to 200 
mg/day) should be indefinitely continued. Doses should 
be increased with advancing age or when intercurrent 
illnesses occur (9). Women with a child with vitamin 
B6-dependent seizures are recommended to receive this 
vitamin during subsequent pregnancies (9). 
Since this study was a clinic-based series, it might not 
represent the full spectrum of patients with WS. Besides, 
many patients were referred to us after being treated for 
a while and their initial clinical and EEG findings could 
not be ascertained. Therefore, we did not try to classify 
the patients to idiopathic or symptomatic in this paper.
In conclusion, WS is a rare age-dependent epileptic 
encephalopathy characterized by epileptic spasms, a 
specific EEG pattern (hypsarrhythmia), and psychomotor 
retardation which begins in the first year of life. It is 
often refractory to usual antiepileptic drugs. However, 
rarely, treatable genetic disorders (e.g., pyridoxine-
dependent seizures) should be considered in those with 
no other evident diagnosis. The accurate determination 
of etiology is now becoming more possible (13).
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more or less similar in various studies. Sex ratio (male to 
female) and age of onset of WS in our study were similar 
to the previous reports, as well (8). The hallmark of this 
syndrome is epileptic spasms, as the prominent seizure 
type. In our study, all patients with new-onset WS and 
most treated patients (92%) had epileptic spasms, while 
other seizure types were reported in some patients, 
particularly in those who had the syndrome for some 
time and were being treated. In previous studies, similar 
results have been reported (7). Epilepsy risk factors 
particularly perinatal complications and comorbid 
neurological and medical conditions observed in our 
patients were also more or less similar to the previous 
studies (7). Electroencephalography showed typical 
hypsarrhythmia in 59.4% and modified hypsarrhythmia 
or atypical presentations in 40.6% of our patients. In 
a Taiwanese study, the rate of typical hypsarrhythmia 
was 46% (8). Atypical EEG presentations have been 
reported in previous studies (7) and EEG findings other 
than hypsarrhythmia should be expected in patients with 
WS. In our WS patients, brain imaging abnormalities 
were similar to the previous studies (7) showing normal 
results in about two-fifths and non-specific atrophy 
in almost one-thirds of the patients. Other laboratory 
studies are often normal or non-specific; however, in a 
minority of the patients, inborn errors of metabolism can 
be detected and at times, treated. 
West syndrome is often considered as a drug-resistant 
disease. Although they are rarely treatable, genetic 
disorders should be considered in those in whom no 
other diagnosis is evident. Pyridoxine (B6)-dependent 
seizure is a rare autosomal recessive disorder that usually 
presents with intractable seizures including spasms 
in early years of life. The seizures can be completely 
controlled by administration of vitamin B6; however, if 
not treated promptly, irreversible neurological damage 
may occur. Vitamin B6 should be administered under 
EEG monitoring as a diagnostic test in all infants and 
young children with epilepsy when no other diagnosis is 
evident. Parenteral B6 injection confirms the diagnosis. 
Clinical seizures stop within a few minutes and epileptic 
EEG discharges subside within a few hours after the 
intravenous injection of 50 to 200 mg of B6 (9-11). 
Acute hypotonia and apnea has been reported after 
intravenous B6 administration to infants after long-time 
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Table 1. EEG Findings in Patients with West Syndrome
Finding
All patients New-onset patients
Number (Percent) Number (Percent)
Background abnormality 25 (78.1) 8 (100)
Hypsarrhythmia 19 (59.4) 5 (62.5)
GPFA 10 (31.3) 2 (25)
Slow Spike-wave complex 8 (25) 3 (37.5)
Multifocal spikes 6 (18.8) 1 (12.5)
Burst-Suppression 1 (3.1) 0
GPFA: generalized paroxysmal fast activity.
Table 2. Brain MRI Findings in Patients with West Syndrome
Finding Number Percent
Normal 15 47
Brain atrophy 11 34.5
Hypoxic-ischemic changes 3 9
Schizencephaly 1 3
Not performed 2 6.5
Fig 1. Age of onset in patients with West syndrome (mean ± standard 
deviation was 4.99 ± 3.06 months). Minimum age of onset was the 
neonatal period and maximum age was 12 months.
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